Establishment Labs Holdings Inc. (ESTA)
NASDAQ · Healthcare
Establishment Labs Holdings Inc. EBITDA 2017–2025
Establishment Labs Holdings Inc. annual/quarterly ebitda history and growth rate from 2021 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Establishment Labs Holdings Inc. ebitda for the quarter ending March 31, 2026 was -4.9 M, a 68.00% decrease year-over-year.
- Establishment Labs Holdings Inc. ebitda for the twelve months ending March 31, 2026 was -35.3 M, a 27.32% decrease year-over-year.
- Establishment Labs Holdings Inc. annual ebitda for 2025 was -32.8 M, a 27.56% decrease from 2024.
- Establishment Labs Holdings Inc. annual ebitda for 2024 was -45.3 M, a 27.22% decrease from 2023.
- Establishment Labs Holdings Inc. annual ebitda for 2023 was -62.2 M, a 67.46% increase from 2022.
- Establishment Labs Holdings Inc. annual ebitda for 2022 was -37.2 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Establishment Labs Holdings Inc. EBITDA — FAQ
Establishment Labs Holdings Inc. (ESTA) ebitda over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ESTA's ebitda history?
The chart and table above show Establishment Labs Holdings Inc.'s ebitda by year and by quarter, including the growth rate.